Your browser doesn't support javascript.
loading
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study.
Landewé, Robert; Sieper, Joachim; Mease, Philip; Inman, Robert D; Lambert, Robert G; Deodhar, Atul; Marzo-Ortega, Helena; Magrey, Marina; Kiltz, Uta; Wang, Xin; Li, Mei; Zhong, Sheng; Mostafa, Nael M; Lertratanakul, Apinya; Pangan, Aileen L; Anderson, Jaclyn K.
Affiliation
  • Landewé R; Department Clinical Immunology and Rheumatology, Amsterdam Rheumatology & Clinical Immunology Center, Amsterdam, Netherlands; Department of Rheumatology, Zuyderland Medical Center, Heerlen, Netherlands. Electronic address: landewe@rlandewe.nl.
  • Sieper J; Department of Gastroenterology, Infectious Diseases, and Rheumatology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Mease P; Seattle Rheumatology Associates, Swedish Medical Center and University of Washington, Seattle, WA, USA.
  • Inman RD; Department of Immunology, Toronto Western Hospital, Toronto, ON, Canada.
  • Lambert RG; Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada.
  • Deodhar A; Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA.
  • Marzo-Ortega H; National Institute for Health Research, Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Magrey M; Department of Medicine, Division of Rheumatology, Case Western Reserve University School of Medicine at MetroHealth Medical Center, Cleveland, OH, USA.
  • Kiltz U; Rheumazentrum Ruhrgebiet, Herne, Germany.
  • Wang X; AbbVie, North Chicago, IL, USA.
  • Li M; AbbVie, North Chicago, IL, USA.
  • Zhong S; AbbVie, North Chicago, IL, USA.
  • Mostafa NM; AbbVie, North Chicago, IL, USA.
  • Lertratanakul A; AbbVie, North Chicago, IL, USA.
  • Pangan AL; AbbVie, North Chicago, IL, USA.
  • Anderson JK; AbbVie, North Chicago, IL, USA.
Lancet ; 392(10142): 134-144, 2018 07 14.
Article in En | MEDLINE | ID: mdl-29961640
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spondylitis, Ankylosing / Substance Withdrawal Syndrome / Adalimumab Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2018 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spondylitis, Ankylosing / Substance Withdrawal Syndrome / Adalimumab Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2018 Document type: Article Country of publication: United kingdom